// App-Quantinova.ai

P456 : A LONG READ SEQUENCING AND CRISPR-CAS9 BASED APPROACH FOR RAPID COPY-NUMBER ALTERATION AND STRUCTURAL VARIATION DETECTION IN HEMATOLOGIC MALIGNANCIES

Researchers

Presenter

  • Jens Schrezenmeier

Principal Investigators

  • Jan Eric Straeng

  • Olga Blau

  • Ahmed Elashy

  • Alexandra Lazarides

  • Sabrina Skambraks

  • Bernd Gillien

  • Cornelia Eckert

  • Axel Nogai

  • Igor-Wolfgang Blau

  • Krzysztof Giannopoulos

  • Michael Heuser

  • Konstanze Dhner

  • Lars Bullinger

  • Anna Dolnik

Medical Centers

  • Hämatologie, Onkologie und Tumorimmunologie,Charité Universitätsmedizin Berlin,Berlin,Germany

  • Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Pediatric Hematology and Oncology,Charité-Universitätsmedizin Berlin,Berlin,Germania

  • Department of Internal Medicine III,University of Ulm,Ulm,Deutschland

  • Pediatric Hematology and Oncology,Charité-Universitätsmedizin Berlin,Berlin,Germania

  • Pediatric Hematology and Oncology,Charité-Universitätsmedizin Berlin,Berlin,Germania

  • Department of Internal Medicine III,University of Ulm,Ulm,Deutschland

  • Department of Internal Medicine III,University of Ulm,Ulm,Deutschland

  • Pediatric Hematology and Oncology,Charité-Universitätsmedizin Berlin,Berlin,Germania

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin,Berlin,Allemagne

  • Department of Experimental Hematooncology,Medical Universit

  • Pediatric Hematology and Oncology,Charité-Universitätsmed

  • Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  • Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  • Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation,Hannover Medical School,Hannover,Deutschland

  • Department of Internal Medicine III,University of Ulm,Ulm,Deutschland

  • Hematology, Oncology and Tumo

  • Department of Hematology, Hemostasis,...

  • Hematology, Oncology and Tumorimmunology,Charité-Universitätsmedizin Berlin,Berlin,Germania

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  • Hematology, Oncology and Tumorimmunology,Charité-Universitätsmedizin Berlin,Berlin,Germania

Locations

  • Germany

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Acute myelocytic leukemia

  • Multiple Myeloma

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A